Trademarkia Logo

Australia

AU$
Trademark Search
SPI PHARMA

View On IPO.GOV.AU

SPI PHARMA
Protected: Registered/protected

Last updated on 2 Jan 2025

Owner Info

SPI PHARMA INC.

503 Carr Road

Wilmington DE 19809, UNITED STATES OF AMERICA

Serial Number

2433213 filed on 28 Aug 2023

Correspondent

William C. Wright

Epstein Drangel LLP,

60 East 42nd Street, Suite 1250,

UNITED STATES OF AMERICA

SPI PHARMA

Classification Information

Class [005]
Vaccine adjuvants; drug delivery agents; antacid preparations; aluminium for pharmaceutical purposes; magnesium for pharmaceutical purposes; calcium f Read More

Class [040]
Production of antacid suspensions and tablets, custom manufacture of pharmaceuticals.

Class [042]
Research and testing of pharmaceuticals.

Mark Details

Serial Number

2433213

Registered On

28 Aug 2023

Renewal On

28 Aug 2033

Mark Type

FIGURATIVE

Priority Claim (Convention Details)

Date

8 Mar 2023

Mark Type

US

Legal History

Show more

Status DateAction Taken
2th Jan 2025Amendment to International Registration Contact Requested
15th May 2024International Registration in Australia Protected correspondence sent
14th May 2024International Registration in Australia Protected correspondence sent
14th May 2024IP Right Registration Published
14th May 2024Status change to Registered/Protected
9th May 2024Amendment to International Registration Contact Requested
26th Apr 2024Customer Amendment Made correspondence sent
26th Apr 2024Amendment to Address for Service Requested
8th Mar 2024Application Accepted correspondence sent
7th Mar 2024IP Right has been Examined